RENAISSANCERE HOLDINGS LTDRNR

時価総額
$135.4億
PER
再保険・保険引受ビジネスの大手。高度なリスク選別と資本管理、REMS等の独自モデリングと固定収入重視の投資運用を展開。2023年11月に約30.2億ドルで大型買収。米国・欧州・バミューダ・アジアで展開。
2010年
12月31日
2011年
12月31日
2012年
12月31日
2013年
12月31日
2014年
12月31日
2015年
12月31日
2016年
12月31日
2017年
12月31日
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
2023年
12月31日
2024年
12月31日
Net income (loss)861-90749842686542630-355269950993-103-1,1603,6202,961
Amortization, accretion and depreciation60426052481829310-5917-21-27-135258
Equity in undistributed (earnings) losses of other ventures-24-4019152010-6-641-2-13-118-9
Net realized and unrealized (gains) losses on investments144711643541-69141136-175414821-206-1,63548329
Premiums receivable2315019-17-341052093172334252948871,35812710
Prepaid reinsurance premiums-14-219-11291282119283125631167-223-36
Reinsurance recoverable-302-212-91-34641451,307786-1301381,343442-664-863
Deferred acquisition costs and value of business acquired-10892928891369150-119-30216323--199
Reserve for claims and claim expenses---------9011,1562,9132,598-35817
Unearned premiums-4661527834144342246238512337681,028-227-186
Reinsurance balances payable-29-613431626515031591365966237367-1,040-382
Other-4116-16071-3-85-538223-251-178437259579372
Net cash provided by (used in) operating activities4951667177966614154701,0461,2222,1371,9931,2351,6041,9124,165
Proceeds from sales and maturities of fixed maturity investments trading-6,0898,1938,2517,6839,4828,1039,49111,58617,31415,18715,54422,08621,79723,515
Purchases of fixed maturity investments trading-6,2728,5368,4667,6399,6838,28310,09412,49017,91916,83715,68024,92324,77126,297
Proceeds from sales of equity investments--------------0
Purchases of equity investments--------------0
Proceeds from Sale of Short-Term Investments--------------31,772
Purchases of short term investments--------------31,598
Proceeds from Sale of Other Investments--------------1,087
Purchases of other investments--------------1,526
Purchases of investments in other ventures-39-4-110--21342412557
Return of investments in other ventures--------811982641
Net purchase of Validus-----678---276---2,434-
Net cash provided by (used in) investing activities109315-72-316142-339-165-142-2,537-2,989-2,305-816-3,016-3,823-3,061
Dividends paid – RenaissanceRe common shares565353494654525153596868657581
Dividends paid – preference shares423535252222222230373133353535
RenaissanceRe common share repurchases449192463207515260309189--631,028167-667
Proceeds from Issuance of Common Stock--------250-1,096--1,352-
Proceeds from Issuance of Debt-----446-296-396---741-
Repayment of Medici Revolving Credit Facility-------------30150
Proceeds from Lines of Credit-----------30-7575
Proceeds From Repurchase Of Redeemable Noncontrolling Interest--------------537
Redemptions of third-party redeemable noncontrolling interest shares-62-16561121933-260------943
Taxes paid on withholding shares-------15871212112124
Net cash provided by (used in) financing activities-532-542-539-399-695-84-386291,0661,120665-3027252,589-1,288
Effect of exchange rate changes on foreign currency cash---------246226-17
Net increase (decrease) in cash and cash equivalents---------271358122-665683-201
Income Taxes Paid, Net-------00106-4327100
Interest paid--------51534921467488
Non-cash consideration-------------285-